Fate map of serotonin transporter-expressing cells in developing mouse heart

Genesis

Volumn 45, Issue 11, 2007, Pages 689-695

  Pavone, Luigi Michele ^a   Mithbaokar, Pratibha ^a   Mastellone, Vincenzo ^b   Avallone, Luigi ^a   Gaspar, Patricia ^c   Maharajan, Veeramani ^d   Baldini, Antonio ^e,f  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c INSERM   (France)

^d CNR   (Italy)

^e TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^f TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Cre recombinase; Heart development; Mouse model; Serotonergic system; SERT

Indexed keywords

CELL MARKER; SEROTONIN TRANSPORTER;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MAPPING; GENETIC ANALYSIS; HEART DEVELOPMENT; HEART RIGHT VENTRICLE; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; TRICUSPID VALVE DISEASE;

ANIMALS; CELL LINEAGE; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; MICE; MYOCARDIUM; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

ANIMALIA;

EID: 38049053547     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20343     Document Type: Article

References (31)

1. Bader M, Bohnemeier H, Zollmann FS, Lockley-Jones OE, Ganten D. 2000. Transgenic animals in cardiovascular disease research. Exp Physiol 85:713-731.
2. Black BL. 2007. Transcriptional pathways in second heart field development. Semin Cell Dev Biol 18:67-76.
3. Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J, Evans S. 2003. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5:877-889.
4. Choi DS, Ward SJ, Messaddeq N, Launay JM, Marateaux L. 1997. 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development 124:1745-1755.
5. Cote F, Fligny C, Frames Y, Mallet J, Vodjdani G. 2004. Recent advances in understanding serotonin regulation of cardiovascular function. Trends Mol Med 10:232-238.
6. Engleka KA, Gitler AD, Zhang M, Zhou DD, High FA, Epstein JA. 2005. Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3. Dev Biol 280:396-406.
7. Frishman WH, Grewall P. 2000. Serotonin and the heart. Ann Med 32:195-209.
8. Hansson SR, Mezey E, Hoffman BJ. 1999. Serotonin transporter messenger RNA expression in neural crest-derived structures and sensory pathways of the developing rat embryo. Neuroscience 89:243-265.
9. Huether G, Rittner I, Reimer A, Adler L, Youdim MBH. 1992. Early appearance of serotonin in the embryonal circulation and its action on the developing cardiovascular system of the chick embryo. Biog Amines 8:421-430.
10. Ikeda K, Tojo K, Otsubo C, Udagawa T, Kumazawa K, Ishikawa M, Tokudome G, Hosoya T, Tajima N, Claycomb WC, Nakao K, Kawamura M. 2005. 5-Hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes. Biochem Biophys Res Commun 328:522-525.
11. Ishibashi M, Moriyoshi K, Sasai Y, Shiota K, Nakanishi S, Kageyama R. 1994. Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system. EMBO J 13:1799-1805.
12. Jiang X, Rowitch DH, Soriano P, McMahon AP, Sucov HM. 2000. Fate of the mammalian cardiac neural crest. Development 127:1607-1616.
13. Lauder JM, Wilkie MB, Wu C, Singh S. 2000. Expression of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors in the mouse embryo. Int J Dev Neurosci 18:653-662.
14. Lebrand C, Cases O, Wehné R, Blakely RD, Edwards RH, Gaspar P. 1998. Transient developmental expression of monoamine transporters in the rodent forebrain. J Comp Neurol 401:506-524.
15. Marcos E, Adnot S, Pham MH, Nosjean A, Raffestin B, Hamon M, Eddahibi S. 2003. Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am J Respir Crit Care Med 168:487-493.
16. Mekontso-Dessap A, Brouri F, Pascal O, Lechat P, Hanoun N, Lanfumey L, Seif I, Benhaiem-Sigaux N, Kirsch M, Hamon M, Adnot S, Eddahibi S. 2006. Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation 113:81-89.
17. Moiseiwitsch JM, Lauder JM. 1995. Serotonin regulates mouse cranial neural crest migration. Proc Natl Acad Sci USA 92:7182-7186.
18. Mortensen OV, Kristensen AS, Rudnick G, Wiborg O. 1999. Molecular cloning, expression and characterization of a bovine serotonin transporter. Brain Res Mol Brain Res 71:120-126.
19. Nakamura T, Colbert MC, Robbins J. 2006. Neural crest cells retain multipotential characteristics in the developing valves and label the cardiac conduction system. Circ Res 98:1547-1554.
20. Nebigil CG, Maroteaux L. 2001. A novel role for serotonin in heart. Trends Cardiovasc Med 11:329-335.
21. Nemecek GM, Coughlin SR, Handley DA, Moskowitz MD. 1986. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci USA 83:674-678.
22. Ni W, Watts SW. 2006. 5-Hydroxytryptamine in the cardiovascular system: Focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol 33:575-583.
23. Paraskevaidis I, Parissis JT, Fountoulaki K, Filippatos G, Kremastinos D. 2006. Selective serotonin re-uptake inhibitors for the treatment of depression in coronary artery disease and chronic heart failure: Evidence for pleiotropic effects. Cardiovasc Hematol Agents Med Chem 4:361-367.
24. Sari Y, Zhou FC. 2003. Serotonin and its transporter on proliferation of fetal heart cells. Int J Dev Neurosci 21:417-424.
25. Shuey DL, Sadler TW, Lauder JM. 1992. Serotonin as a regulator of craniofacial morphogenesis: Site specific malformations following exposure to serotonin uptake inhibitors. Teratology 46:367-378.
26. Soriano P. 1999. Generalized lac-Z expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71.
27. Vanhoutte PM. 1991. Platelet-derived serotonin, the endothelium, and cardiovascular disease. J Cardiovasc Pharmacol 17:S6-S12.
28. Villalon CM, de Vries P, Saxena PR. 1997. Serotonin receptors as cardiovascular targets. Drug Discov Today 2:294-300.
29. Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, Grohmann M, Vowinckel J, Alamo Bethencourt V, Wilhelm CS, Ahnert-Hilger G, Bader M. 2003. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115:851-862.
30. Yavarone MS, Shuey DL, Tamir H, Sadler TW, Lauder JM. 1993. Serotonin and cardiac morphogenesis in the mouse embryo. Teratology 47:573-584.
31. Zhuang X, Masson J, Gingrich JA, Rayport S, Hen R. 2005. Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J Neurosci Methods 143:27-32.